Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Valeant to buy Medicis Pharmaceutical
The transaction, which values Medicis’s common stock nearly $2.6bn, was approved by the Boards of Directors of both companies. Valeant’s chairman and chief executive officer Michael Pearson said
The transaction, which values Medicis’s common stock nearly $2.6bn, was approved by the Boards of Directors of both companies. Valeant’s chairman and chief executive officer Michael Pearson said
ATX-101, a injectable facial aesthetic drug under clinical investigation for the reduction of submental fat, is a proprietary formulation of synthetic sodium deoxycholate, a well-characterised component of human
AVP-923 is a combination of the active ingredient dextromethorphan hydrobromide and low dose quinidine sulfate, which serves to increase the bioavailability of dextromethorphan, the ingredient active in the
DuraSite 2 is expected to increase the tissue penetration for topically delivered ocular drugs and improve dosing convenience, according to the company. The data published by the company
The Initiator+ Alstra is useful for peptide chemists synthesizing peptides, peptoids, PNA and peptidomimetics, including complex modifications, for both small and large scale synthesis from 5µmol to 2mmol.
The agreement will allow the NHS trusts to select the electronic care records solutions of their choice and enable CSC to market the Lorenzo solution to NHS trusts
TIP is intended for use in CF patients aged six years and older whose lung function is within a certain range. The AIDAC approval was based on three
The validation solution, Globalvalidator, provides life sciences firms with capabilities such as viewing of envelope information, latest FDA validation sets, fast validation and Q+A36 best practice validation. The
Pennsaid is a topical non-steroidal anti-inflammatory drug (NSAID). Pennsaid 2%, which is not approved by the FDA, contains 2% diclofenac sodium compared to 1.5% for original Pennsaid. If
The open label study will assess the safety, tolerability and optimal dose of the antibody in up to 44 adult patients with malignant solid tumors and will even